Crossmark

Dexmedetomidine, an α2 agonist, increases the morphine analgesic effect and decreases morphine tolerance development by suppressing oxidative stress and TNF/IL-1 signalling pathway in rats

Crossref DOI link: https://doi.org/10.1016/j.redare.2022.04.002

Published Print: 2023-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Avci, O. http://orcid.org/0000-0003-0743-754X
Taskiran, A.S. http://orcid.org/0000-0002-5810-8415
Gundogdu, O. http://orcid.org/0000-0002-8864-0015
License Information

Text and Data Mining valid from 2023-06-01
More Information

This article is maintained by: Elsevier

Article Title: Dexmedetomidine, an α2 agonist, increases the morphine analgesic effect and decreases morphine tolerance development by suppressing oxidative stress and TNF/IL-1 signalling pathway in rats

Journal Title: Revista Española de Anestesiología y Reanimación (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.redare.2022.04.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.redar.2022.04.003

Content Type: article

Copyright: © 2023 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below